Factors associated with risk of malaria infection among pregnant women in Lagos, Nigeria

Infectious Diseases of Poverty

Wellington A Oyibo¹  Chimere O Agomo² 

[1] ANDI Centre of Excellence for Malaria Diagnosis, International Malaria, Microscopy Training and RDT QA Programme, WHO/TDR/FIND Malaria Specimen Bank Site, Department of Medical Microbiology and Parasitology, College of Medicine, University of Lagos, Idi-Araba, Lagos, Nigeria;Malaria Research Laboratory, Nigerian Institute of Medical Research, PMB 2013, Yaba, Lagos, Nigeria

关键词: Malaria in pregnancy in Lagos;    Maternal age;    Insecticide spray;    Risk factors;    Pregnancy;    Malaria;   

Others  :  804021
DOI  :  10.1186/2049-9957-2-19

 received in 2013-03-06, accepted in 2013-08-28,  发布年份 2013

【 摘 要 】

Background

Pregnant women living in an area of stable malaria transmission such as Lagos, Nigeria, have been identified as being at an increased risk of the effects of malaria infection. In this area, most of the infections are asymptomatic which means they are overlooked and untreated much to the detriment of the mother and her foetus. The reality of scaled-up malaria interventions with long-lasting insecticide treated nets, vector control, artemisinin combination therapy (ACT) and intermittent preventive treatment of malaria pregnancy (IPTp) using sulphadoxine pyrimethamine (SP) is that it is also essential to determine the risk factors at play in these kinds of circumstances. This study was aimed at identifying the factors associated with risk of malaria infection in pregnant women in Lagos, Southwest Nigeria.

Methods

Demographic information and malaria prevention practices of the pregnant women studied were captured using structured questionnaire. Microscopy was used to establish malaria infection, species identification and parasite density. Relative risk and multivariate logistic regression analysis were used to compare factors associated with malaria in pregnant women.

Results

Malaria microscopy details, demographic information and malaria prevention practices of the pregnant women were obtained using a structured questionnaire. The prevalence of malaria using peripheral blood from 1,084 pregnant women that participated in the study was 7.7%. Plasmodium falciparum (P. falciparum) was seen in 95.2% of the cases as either mixed infection with P. malariae (3.6%) or as a mono infection (91.6%). Malaria preventive practices associated with a significant reduction (P<0.05) in the malaria infection was the use of insecticide sprays (RR = 0.36, 95 C.I. 0.24-0.54), and the combined use of insecticide spray and insecticide-treated nets (ITN) (RR= 6.53, 95% C.I. 0.92-46.33). Sleeping under ITN alone (RR = 1.07, 95% C.I. 0.55-2.09) was not associated with significant reduction in malaria infection among the study participants with malaria parasitaemia. Young maternal age (<20years) (RR = 2.86, 95% C.I. 1.48 – 5.50), but not primigravidity (RR = 1.36, 95% C.I. 0.90-2.05), was associated with an increased risk of malaria infection during pregnancy. After a multivariate logistic regression, young maternal age (OR = 2.61, 95% C.I. 1.13 – 6.03) and the use of insecticide spray (OR = 0.38, 95% C.I. 0.24-0.63) were associated with an increase and a reduction in malaria infection, respectively.

Conclusion

Malaria prevalence was low among the pregnant women studied. Young maternal age and non-usage of insecticidal spray were the main factors associated with an increased risk of malaria infection among pregnant women in Lagos, Nigeria.

【 授权许可】

   
2013 Agomo and Oyibo; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]World Health Organization: World Malaria Report. Switzerland: World Health Organization; 2012.
• [2]Meeusen EN, Bischof RJ, Lee CS: Comparative T-cell responses during pregnancy in large animals and humans. Am J Reprod Immunol 2001, 46:169-179.
• [3]Riley EM, Hviid L, Theander TG: Malaria. In Parasitic Infections and the Immune System. Edited by Kierszenbaum F. New York: Academic Press; 1994.
• [4]Anorlu RI, Odum CU, Essien EE: Asymptomatic malaria parasitaemia in pregnant women at booking in a primary health care facility in a periurban community in Lagos Nigeria. Afr J Med Med Sci 2001, 30:39-41.
• [5]Mwanziva C, Shekalaghe S, Ndaro A, Mengerink B, Megiroo S, Mosha F, Sauerwein R, Drakeley C, Gosling R, Bousema T: Overuse of artemisinin-combination therapy in Mtowa Mbu (river of mosquitoes), an area misinterpreted as high endemic for malaria. Malar J 2008, 7:232.
• [6]Staalsoe T, Shulman CE, Buhner JN, Kawuondo K, Marsh K, Hviid L: Variant surface antigen-specific IgG and protection against clinical consequences of pregnancy-associated Plasmodium falciparum malaria. Lancet 2004, 363:283-289.
• [7]Brabin BJ: An analysis of malaria in pregnancy in Africa. Bull World Health Organ 1983, 61:1005-1016.
• [8]Steketee RW, Nahlen BL, Parise ME, Menendez C: The burden of malaria in pregnancy in malaria-endemic areas. Am J Trop Med Hyg 2001, 64:28-35.
• [9]Newman RD, Hailemariam A, Jimma D, Degifie A, Kebede D, Rietveld AE, Nahlen BL, Barnwell JW, Steketee RW, Parise ME: Burden of malaria during pregnancy in areas of stable and unstable transmission in Ethiopia during a non epidemic year. J Infect Dis 2003, 187:1765-1772.
• [10]Rogerson SJ, Boeuf P: New approaches to malaria in pregnancy. Parasitology 2007, 134:1883-1893.
• [11]Kalanda G, Hill J, Verhoeff F, Brabin B: Comparative efficacy of chloroquine and sulfadoxine-pyrimethamine in pregnant women and children: a metaanalysis. Trop Med Int Health 2006, 11:569-577.
• [12]World Health Organization: World Malaria Report. Roll Back Malaria. Geneva: World Health Organization; 2005.
• [13]Lengeler C: Insecticide-treated bednets and curtains for preventing malaria. Cochrane Database Syst Rev 2004, 2:1-57. doi:10.1002/14651858.CD000363.pub2. Art. No.: CD000363
• [14]TerKuile FO, Terlouw DJ, Phillips-Howard PA, Hawley WA, Friedman JF, Kariuki SK, Shi YP, Kolezak MS, Lal AA, Vulule JM, Nahlen BL: Reduction of malaria during pregnancy by permethrin-treated bed nets in an area of intense perennial malaria transmission in western Kenya. Am J Trop Med Hyg 2003, 64(2 Suppl):50-60.
• [15]Hill J, Lines J, Rowland M: Insecticide-treated nets. AdvParasitol 2006, 61:77-128.
• [16]Federal Ministry of Health (FMOH): Malaria situation analysis document. Nigeria: Federal Ministry of Health; 2000.
• [17]Okwa OO: The status of malaria among pregnant women: A Study in Lagos, Nigeria. Afr J Reprod Health 2003, 7:77-83.
• [18]Kagu MB, Kawuwa MB, Gadzama GB: Anaemia in pregnancy: A cross-sectional study of pregnant women in a Sahelian tertiary hospital in Northeastern Nigeria. J ObstetGynaecol 2007, 27:676-679.
• [19]Adefioye OA, Adeyeba OA, Hassan WO, Oyeniran OA: Prevalence of malaria parasite infection among pregnant women in Osogbo, Southwest Nigeria. American-Eurasian J Sci Res 2007, 2:43-45.
• [20]Tayo AO, Akinola OI, Shittu LAJ, Ottun TA, Bankole MA, Akinola RA, Shittu RK, Okunribido AI: Prevalence of malaria parasitaemia in the booking antenatal (ANC) patients at the Lagos state university teaching hospital. Afr J Biotechnol 2009, 8(15):3628-3631.
• [21]Prudhomme O'Meara W, Barcus M, Wongsrichanalai C, et al.: Reader technique as a source of variability in determining malaria parasite density by microscopy. Malar J 2006, 5:118.
• [22]Ohrt C, Obare P, Nanakorn A, Adhiambo C, Awuondo K, O'Meara WP, Remich S, Martin K, Cook E, Chretien JP, Lucas C, Osoga J, McEvoy P, Owaga ML, Odera JS, Ogutu B: Establishing a malaria diagnostic center of excellence in Kisumu Kenya. Malar J 2007, 6:79.
• [23]Marchesini P, Crawley J: Reducing the burden of malaria in pregnancy. Roll Back Malaria. World Health Organization 2004. Mera I-IV
• [24]Baker FJ, Silverton RE: The full blood count. In Introduction to medical laboratory technology. 6th edition. London: Butterworths; 1985:320-323.
• [25]Federal Ministry of Health (FMOH): National diagnosis and treatment policy. Abuja –Nigeria: Federal Ministry of Health Nigeria, National Malaria and Vector Control Division; 2010.
• [26]Steffen R, de Bernardis C, Baños A: Travel epidemiology – a global perspective. Int J Antimicrob Agents 2003, 21:89-95.
• [27]World Health Organization: Basic laboratory methods in medical parasitology. Geneva, Switzerland: World Health Organization; 2010.
• [28]Marielle KBA, Denisa EIC, Modeste MM, Eric K, Pierre BM, Elie M, Maryvome K: Prevalence of Plasmodium falciparum infection in pregnant women in Gabon. Malar J 2003, 2:1-17.
• [29]Adam I, Khamis AH, Elbashir MI: Prevalence and risk factors for Plasmodium falciparum malaria in pregnant women of eastern Sudan. Malar J 2005, 4:18.
• [30]Elliott SR, Brennan AK, Beeson JG, Tadesse E, Molyneux ME, Brown GV, Rogerson SJ: Placental Malaria induces variant-specific antibodies of the Cytophilic Subtypes Immunoglobulin G1 (IgG1) and IgG3 That Correlate with Adhesion Inhibitory Activity. Infect Immun 2005, 73:5903-5907.
• [31]Tako EA, Zhou A, Lohoue J, Leke R, Taylor DW, Leke RFG: Risk factor for placental malaria and its effect on pregnancy outcome in Yaounde, Cameroon. Am J Trop Med Hyg 2005, 72:236-242.
• [32]Roll Back Malaria: The African Summit on Roll Back Malaria Abuja, 25 April 2000. : WHO/CDS/RBM/2000.17; 2000.
• [33]Marchant T, Schellenberg JA, Edgar T, Nathan R, Abdulla S, Muasa O, Mponda H, Lengeler C: Socially marketed insecticide-treated nets improve malaria and anaemia in pregnancy in Southern Tanzania. Trop Med Int Health 2002, 7(2):149-158.
• [34]Opiyo P, Mukabana R, Kiche I, Mathenge E, Killeen GF, Fillinger U: An exploratory study of community factors relevant for participatory malaria control on Rusinga Island, western Kenya. Malar J 2007, 6:48.
• [35]Ankomah A, Adebayo SB, Arogundade ED, Anyanti J, Nwokolo E, Ladipo O, Meremikwu MM: Determinants of insecticide-treated net ownership and utilization among pregnant women in Nigeria. BMC Public Health 2012, 12:105.
• [36]Gamble C, Ekwaru PJ, Garner P, ter Kuile F: Insecticide-treated nets for the prevention of malaria in pregnancy: A systematic review of randomized controlled trials. PLoS Med 2006, 4:e107. doi:10.1371/journal.pmed. 0040107
• [37]Ogungbamigbe TO, Ojurongbe O, Ogunro PS, Okanlawon BM, Kolawole SO: Chloroquine resistant Plasmodium falciparum malaria in Osogbo Nigeria: efficacy of amodiaquine + sulfadoxine-pyrimethamine and chloroquine + chlorpheniramine for treatment. MemInstOswaldo Cruz 2008, 103(1):79-84.
• [38]Happi CT, Gbotosho GO, Folarin OA, Sowunmi A, Bolaji OM, Fateye BA, Kyle DE, Milhous W, Wirth DF, Oduola AM: Linkage disequilibrium between two distinct loci in chromosomes 5 and 7 of Plasmodium falciparum and in vivo chloroquine resistance in Southwest Nigeria. Parasitol Res 2006, 100(1):141-148.
• [39]Federal Ministry of Health: National malaria treatment policy. Nigeria: Federal Ministry of Health; 2005.
• [40]Coulibaly SO, Desire N, Traore S, Kone B, Magnussen P: Therapeutic efficacy of sulphadoxine-pyrimethamine and chloroquine for the treatment of uncomplicated malaria in pregnancy in Burkina Faso. Mal J 2006, 5:49. doi:10.1186/1475-2875-5-49
• [41]Federal Ministry of Health: National guidelines and strategies for malaria prevention and control during pregnancy. Nigeria: Federal Ministry of Health; 2005.